China incorporates antigen detection into COVID-19 testing
BEIJING, March 11 (Xinhua) -- China has added antigen detection as an option for COVID-19 testing among the public, the National Health Commission said Friday.
Antigen detection results can now be used in screening for COVID-19 infection, while nucleic acid test results are still decisive for diagnosis, according to a trial antigen-detection action plan issued by the commission.
Community residents can purchase antigen-detection reagents through drug stores or online platforms and perform self-testing, the plan states.
This new approach is aimed at boosting the early discovery of COVID-19 cases, it states.
The Chinese mainland on Thursday reported 397 locally transmitted COVID-19 cases, the National Health Commission said Friday.
Thursday also saw over 5.07 million doses of COVID-19 vaccine administered on the Chinese mainland, with the total number reaching over 3.18 billion.
Photos
- Traditional tie-dye products of Buyi ethnic group in Guizhou popular among tourists
- Girls from mountainous areas in Hainan pursue football dreams
- Chinese artist forms elaborate images using whisked tea foam in revival of Song Dynasty’s cultural splendor
- Wild lilies in full bloom as snow melts in Xinjiang
Related Stories
- Northeast China city imposes closed management of residents amid COVID-19 outbreak
- COVID-19 hospitalization, death rates among black Americans considerably higher than white Americans: study
- Shanghai Disney Resort to operate with reduced capacity for epidemic control
- U.S. sees COVID-19 situation easing as WHO cautions against end of restrictions
- Pfizer-BioNTech COVID-19 vaccine greatly reduces risk of Omicron infection among children: CDC
Copyright © 2022 People's Daily Online. All Rights Reserved.